More people appear to be walking away from Affordable Care Act coverage or switching to cheaper plans for 2026 compared to this time last year, according to early enrollment data from several states.

Anthropic is launching Claude Code in Slack, allowing developers to delegate coding tasks directly from chat threads. The beta feature, available Monday as a research preview, builds on Anthropic’s ...

Full Coverage Foundation Made Easy with Mom & Sister #Maybelline #FitMe #MakeupTutorial #BackToSchool Map shows how Greenland’s rare earth minerals compare to rest of world Early results show Taylor ...

After an unforgettable end to the 2025 season, the Circuit Ricardo Tormo plays host to a crucial one-day Valencia Test. It’s the first opportunity for the riders to try some fresh parts and our first ...

Abstract: Obsolete and redundant tests increase regression testing costs. Therefore, developers should remove them from test suites; however, identifying these tests is non-trivial. Automated ...

Breaking down what games CBS and Fox will be broadcasting all over the country for the first football Sunday of the. year. After a very long offseason, the NFL has finally arrived. The 2025 season is ...

Traditional Medicare will face greater use of prior authorizations under a pilot program by the Centers for Medicare & Medicaid Services, potentially eroding one area that enrollees like about their ...

Increasing prior authorizations would 'undercut one of the immense benefits of traditional Medicare' Traditional Medicare currently faces fewer prior authorizations than Medicare Advantage, but that ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Apache Maven is a Java build tool and dependency management engine that simplifies the ...

Aug 1 (Reuters) - The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that its Oncodetect™ molecular residual disease (MRD) ...